Lipid lowering agents of natural origin: An account of some promising chemotypes

European Journal of Medicinal Chemistry
2017.0

Abstract

The role of natural products in the drug development and discovery has been phenomenal. There has been an enormous interest in exploring all possible natural sources to identify structures exhibiting pronounced hypolipidemic activity albeit with no toxicity. The present review describes the profile of some interesting naturally occurring compounds and their derivatives as potential hypolipidemic agents. Some of the interesting natural chemotypes that can control the increased levels of plasma lipids and discussed in this review are compactin, lovastatin, gugglesterone, berberine, lupeol, phytol, polyprenol, aegeline, 4-hydroxyisoleucine, α-asarone, resveratrol, esculeoside A, swertiamarin, rutin, saucerneol B, curcumin and a clerodane diterpene.

Knowledge Graph

Similar Paper

Lipid lowering agents of natural origin: An account of some promising chemotypes
European Journal of Medicinal Chemistry 2017.0
Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs
Current Topics in Medicinal Chemistry 2020.0
Discovery of C-9 Modified Berberine Derivatives as Novel Lipid-Lowering Agents
Chemical and Pharmaceutical Bulletin 2021.0
Lipid-Lowering Activities of Cucurbitacins Isolated from <i>Trichosanthes cucumeroides</i> and Their Synthetic Derivatives
Journal of Natural Products 2020.0
Berberine Analogues as a Novel Class of the Low-Density-Lipoprotein Receptor Up-Regulators: Synthesis, Structure−Activity Relationships, and Cholesterol-Lowering Efficacy
Journal of Medicinal Chemistry 2009.0
Evaluation of the effects of natural isoquinoline alkaloids on low density lipoprotein receptor (LDLR) and proprotein convertase subtilisin/kexin type 9 (PCSK9) in hepatocytes, as new potential hypocholesterolemic agents
Bioorganic Chemistry 2022.0
Discovery of 7,9-Disulfatetrahydroberberine as Novel Lipid-Lowering Agents
ACS Omega 2020.0
Synthesis of novel N-(2-hydroxy-2-p-tolylethyl)-amide and N-(2-oxo-2-p-tolylethyl)-amide derivatives and their antidyslipidemic and antioxidant activity
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Discovery and synthesis of novel substituted benzocoumarins as orally active lipid modulating agents
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Synthesis of novel triterpenoid (lupeol) derivatives and their in vivo antihyperglycemic and antidyslipidemic activity
Bioorganic &amp; Medicinal Chemistry Letters 2009.0